1013933-37-3

Potent and selective CRF1receptor antagonist (Kivalues are 12 and >10000 nM for CRF1and CRF2receptors respectively). Attenuates CRF-induced activation of the HPA axisin vivofollowing i.v. administration. Orally active.

Desiccate at RT